CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 87 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2018. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $59,000 | +3.5% | 42,808 | -19.3% | 0.00% | – |
| Q4 2018 | $57,000 | -78.3% | 53,066 | +24.0% | 0.00% | -100.0% |
| Q3 2018 | $263,000 | -42.5% | 42,788 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $457,000 | +33.2% | 42,788 | +33.9% | 0.00% | 0.0% |
| Q1 2018 | $343,000 | +50.4% | 31,963 | -1.9% | 0.00% | – |
| Q4 2017 | $228,000 | -21.9% | 32,592 | -2.5% | 0.00% | -100.0% |
| Q3 2017 | $292,000 | -12.3% | 33,442 | -8.6% | 0.00% | 0.0% |
| Q2 2017 | $333,000 | +112.1% | 36,600 | +84.8% | 0.00% | – |
| Q1 2017 | $157,000 | +3.3% | 19,800 | +16.5% | 0.00% | – |
| Q4 2016 | $152,000 | -50.0% | 17,000 | -2.9% | 0.00% | -100.0% |
| Q3 2016 | $304,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 3,917,622 | $7,365,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 54,092 | $102,000 | 0.06% |
| Carmignac Gestion | 1,937,608 | $3,643,000 | 0.05% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 91,824 | $173,000 | 0.03% |
| SIGNATUREFD, LLC | 121,351 | $228,000 | 0.01% |
| Tekla Capital Management LLC | 165,330 | $311,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 184,000 | $346,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 567,903 | $1,068,000 | 0.01% |
| Integrated Advisors Network LLC | 15,700 | $30,000 | 0.00% |
| WEDBUSH SECURITIES INC | 22,900 | $43,000 | 0.00% |